Clinical Trials Browser

Phase 2 × Suspended × Bevacizumab × Clear all

NCT07011550 2026-03-11

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

Phase 2 Suspended

Gastrointestinal

Microsatellite-stable Colorectal Cancer

NCT05620771 2025-10-20

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

Phase 2 Suspended

Gastrointestinal

Carcinoma, Hepatocellular

NCT05375708 2025-03-28

SIRIUS

Phase 2 Suspended

Gastrointestinal

Colorectal Neoplasms